These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32054828)

  • 1. Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche.
    Shinde A; Paez JS; Libring S; Hopkins K; Solorio L; Wendt MK
    Oncogenesis; 2020 Feb; 9(2):16. PubMed ID: 32054828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites.
    Libring S; Shinde A; Chanda MK; Nuru M; George H; Saleh AM; Abdullah A; Kinzer-Ursem TL; Calve S; Wendt MK; Solorio L
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine Fibronectin Inhibits Breast Cancer Metastasis.
    Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK
    Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
    Mangala LS; Fok JY; Zorrilla-Calancha IR; Verma A; Mehta K
    Oncogene; 2007 Apr; 26(17):2459-70. PubMed ID: 17043648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
    Seo S; Moon Y; Choi J; Yoon S; Jung KH; Cheon J; Kim W; Kim D; Lee CH; Kim SW; Park KS; Lee DH
    Am J Cancer Res; 2019; 9(3):597-607. PubMed ID: 30949413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
    Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
    Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O; Wang Z; Griffin M
    Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
    Herman JF; Mangala LS; Mehta K
    Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
    Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
    Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
    Forsprecher J; Wang Z; Nelea V; Kaartinen MT
    Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin-Expressing Mesenchymal Tumor Cells Promote Breast Cancer Metastasis.
    Jun BH; Guo T; Libring S; Chanda MK; Paez JS; Shinde A; Wendt MK; Vlachos PP; Solorio L
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32911713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
    Shao M; Cao L; Shen C; Satpathy M; Chelladurai B; Bigsby RM; Nakshatri H; Matei D
    Cancer Res; 2009 Dec; 69(24):9192-201. PubMed ID: 19951993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.
    Fisher ML; Adhikary G; Xu W; Kerr C; Keillor JW; Eckert RL
    Oncotarget; 2015 Aug; 6(24):20525-39. PubMed ID: 25971211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
    Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
    Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
    Agnihotri N; Mehta K
    Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model.
    Mazumdar A; Urdinez J; Boro A; Arlt MJE; Egli FE; Niederöst B; Jaeger PK; Moschini G; Muff R; Fuchs B; Snedeker JG; Gvozdenovic A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.
    Ayinde O; Wang Z; Pinton G; Moro L; Griffin M
    Oncotarget; 2019 Jul; 10(44):4556-4569. PubMed ID: 31360304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis.
    Schwager SC; Young KM; Hapach LA; Carlson CM; Mosier JA; McArdle TJ; Wang W; Schunk C; Jayathilake AL; Bates ME; Bordeleau F; Antonyak MA; Cerione RA; Reinhart-King CA
    Elife; 2022 Dec; 11():. PubMed ID: 36475545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.